Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
Other
Sonoma Pharmaceuticals Inc
Other Peer Comparison
Competitive Other Analysis
Latest Figures & CAGR of Competitors
Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Other
-$5k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
42%
|
|
Johnson & Johnson
NYSE:JNJ
|
Other
-$1B
|
CAGR 3-Years
-237%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other
$22m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
Pfizer Inc
NYSE:PFE
|
Other
-$582m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Other
-$325m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-19%
|
|
Eli Lilly and Co
NYSE:LLY
|
Other
-$443.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-52%
|
See Also
What is Sonoma Pharmaceuticals Inc's Other?
Other
-5k
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Other amounts to -5k USD.
What is Sonoma Pharmaceuticals Inc's Other growth rate?
Other CAGR 10Y
42%
Over the last year, the Other growth was 96%.